Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, 12 Week Double Blind Placebo Controlled Randomized Study Of Etanercept On A Background Nsaid In The Treatment Of Adult Subjects With Non Radiographic Axial Spondyloarthritis With A 92 Week Open Label Extension

NCT01258738 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01258738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01258738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, 12 Week Double Blind Placebo Controlled Randomized Study Of Etanercept On A Background Nsaid In The Treatment Of Adult Subjects With Non Radiographic Axial Spondyloarthritis With A 92 Week Open Label Extension
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2011
Completion date
October 31, 2014
Enrollment
225 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

spondylitis, ankylosing